Juno Therapeutics Claimed Company

Juno Therapeutics, a clinical-stage company, develops immunotherapies for the treatment of cancer. read more

EMPLOYEE PARTICIPANTS: 6

TOTAL RATINGS: 165

CEO: Hans Bishop

HR or Marketing? Claim Your Free Employer Account

Juno Therapeutics CEO & Leadership Team Ratings

Hans Bishop and the Juno Therapeutics leadership team are scored an A+ by 5 employees placing it in the Top 5% of companies sized 501-1,000 Employees on Comparably. The Leadership score includes details about how employees evaluate their executive team, CEO and manager.

Caucasian employees have the most favorable ratings for their leadership team.

Based on 41 ratings, the Leadership score of 83/100 combines employee feedback on their CEO (86/100), Manager (82/100), and Executive Team (74/100).

Hans Bishop Juno Therapeutics CEO Rating

Top 5% Compared to other companies of similar size in Seattle

A+

86 / 100

Hans Bishop the CEO of Juno Therapeutics received an average score of 86 from Juno Therapeutics employees.

Male employees at Juno Therapeutics rate the CEO the highest.

Male: 88

Female:

Caucasian employees at Juno Therapeutics rate the CEO the highest.

Caucasian: 88

Juno Therapeutics Manager Rating

Top 10% Compared to other companies of similar size in Seattle

82 / 100

Managers received an average score of 82 from Juno Therapeutics employees.

Male employees at Juno Therapeutics rate their Manager the highest.

Male: 83

Female:

Caucasian employees at Juno Therapeutics rate their Manager the highest.

Caucasian: 83

Juno Therapeutics Executive Team Rating

Top 25% Compared to other companies of similar size in Seattle

74 / 100

The Executive team received an average score of 74 from Juno Therapeutics employees.

Male employees at Juno Therapeutics rate the Executive Team the highest.

Male: 72

Female:

Caucasian employees at Juno Therapeutics rate the Executive Team the highest.

Caucasian: 72

Rate your company